VLGC Virologic (MM)

ViroLogic to Present at the Deutsche Bank Securities 30th Annual Health Care Conference on May 4, 2005 SOUTH SAN FRANCISCO, Calif., April 22 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC) announced today that William D. Young, CEO and Chairman, is scheduled to present a corporate overview at the Deutsche Bank Securities 30th Annual Health Care Conference on Wednesday, May 4, 2005 at 8:00 a.m. The event will be held at the Hyatt Regency Hotel in Baltimore, Maryland from May 2-4, 2005. To access the live audio broadcast or the subsequent archived recording log on to http://www.virologic.com/ and go to the investor relations section. The archived version of the webcast will be available online for one month. About ViroLogic ViroLogic is a biotechnology company advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at http://www.virologic.com/. DATASOURCE: ViroLogic, Inc. CONTACT: Alfred Merriweather, Vice President and CFO of ViroLogic, Inc., +1-650-635-1100; or Carolyn Bumgardner Wang of WeissComm Partners, +1-415-692-4218, or , for ViroLogic, Inc. Web site: http://www.virologic.com/

Copyright